Fig. 4.

Gemcitabine reduces MDSC in Panc02-bearing mice. On day 27 after Panc02 injection, a spleens and b tumors were collected from tumor-bearing mice treated with 120 mg/kg of gemcitabine. CD11b⁺Gr1⁺ cells were measured in the splenocytes by flow cytometry. *p < 0.001; **p < 0.01